Constructing Spatiotemporally Controllable Biocatalytic Cascade in RBC Nanovesicles for Precise Tumor Therapy Based on Reversibly Induced Glucose Oxidase‐Magnetoferritin Dimers
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Xinjie Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Departm…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Chemodynamic therapy is a promising tumor treatment strategy. However, it remains a great challenge to overcome the unavoidable off‐target damage to normal tissues. In this work, it is discovered that magnetoferritin (M‐HFn, biomimic peroxidase) can form nanocomplexes with glucose oxidase (GOD) in the presence of glucose, thus inhibiting the enzyme activity of GOD. Interestingly, GOD&M‐HFn (G‐M) nanocomplexes can dissociate under near‐infrared (NIR) laser, reactivating the enzyme cascade. Based on this new finding, a spatiotemporally controllable biocatalytic cascade in red blood cell (RBC) nanovesicles (G‐M@RBC‐A) is fabricated for precise tumor therapy, which in situ inhibits enzyme cascade between GOD and M‐HFn during blood circulation and reactivates the cascade activity in tumor site by NIR laser irradiation. In RBC nanovesicles, GOD is grabbed by M‐HFn to form G‐M nanocomplexes in the presence of glucose, thus inhibiting the Fenton reaction and reducing side effects. However, after NIR laser irradiation, G‐M nanocomplexes are spatiotemporally dissociated and the cascade activity is reactivated in the tumor site, initiating reactive oxygen species damage to cancer cells in vivo. Therefore, this work provides new insight into the fabrication of spatiotemporally controllable biocatalytic cascade for precise cancer therapy in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, Ch…
ORCID-Profile: Jian Dai
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Chen, X., Ruan, M., Wu, J., Zhu, T., Wen, Y., Li, X., Yang, C., Zong, X., Yuan, P., Li, Y., Yan, X., Xue, W., & Dai, J. (2023). Constructing Spatiotemporally Controllable Biocatalytic Cascade in RBC Nanovesicles for Precise Tumor Therapy Based on Reversibly Induced Glucose Oxidase‐Magnetoferritin Dimers. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300205
Vancouver
Chen X, Ruan M, Wu J, Zhu T, Wen Y, Li X, et al. Constructing Spatiotemporally Controllable Biocatalytic Cascade in RBC Nanovesicles for Precise Tumor Therapy Based on Reversibly Induced Glucose Oxidase‐Magnetoferritin Dimers. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300205
BibTeX
@article{Chen2023,
author = {Chen, Xinjie and Ruan, Miaoliang and Wu, Jinpei and Zhu, Tianci and Wen, Yaoqi and Li, Xiaodi and Yang, Caiqi and Zong, Xiaoqing and Yuan, Pengfei and Li, Yuchao and Yan, Xiaodie and Xue, Wei and Dai, Jian},
title = {Constructing Spatiotemporally Controllable Biocatalytic Cascade in RBC Nanovesicles for Precise Tumor Therapy Based on Reversibly Induced Glucose Oxidase‐Magnetoferritin Dimers},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300205}
}
EUVIMED